
NRC
USDNational Research Corporation Common Stock (Delaware)
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$14.340
Haut
$14.775
Bas
$14.135
Volume
0.01M
Fondamentaux de l'Entreprise
Capitalisation Boursière
333.1M
Industrie
Health Information Services
Pays
United States
Statistiques de Trading
Volume Moyen
0.10M
Bourse
NMS
Devise
USD
Intervalle sur 52 Semaines
Rapport d'Analyse IA
Dernière mise à jour: 3 nov. 2025NRC Stock Update: National Research Corp Shows Volatile Recovery Pattern
Price Movement Summary
- Recent Close: $13.43 (Nov 3) after bouncing from $11.28 low (Oct 10)
- 3-Month Range: $11.28 - $16.14 (-30% peak-to-trough)
- Key Catalyst: October 28 surge (+16% on 273k volume - 2.7x average)
Breaking Down the Action
-
August Strength Steady climb from $12.58 to $16.03 (27% gain) on average volume, peaking Sept 9.
-
September Breakdown Sharp 31% collapse from $16.03 to $11.48 over six weeks, accelerated by high-volume selling Sept 19 (-6.9%) and Sept 29 (-6.2%).
-
October Rebound October 28 explosion ($11.43→$13.25) marked strongest single-day gain since August. Subsequent consolidation between $12.62-$13.45 suggests new trading range forming.
Technical Positioning
- Bullish Signals: MACD crossover + volume surge confirm momentum shift
- Immediate Resistance: $13.45-13.62 area (recent highs & Bollinger upper band)
- Critical Support: $12.02-12.62 zone (October rebound base)
- Volume Profile: Sustained above-average trading since rebound (115k-141k vs 101k avg)
Fundamental Context
| Metric | Value | Implication | |
|---|---|---|---|
| ✅ | ROE | 66.9% | Exceptional capital efficiency |
| ⚠️ | Debt/Equity | 559% | Highly leveraged structure |
| 🔻 | Revenue Growth | -3.4% | Contracting operations |
| 📊 | P/E | 11.57 | Below healthcare sector average |
Strategic Considerations
For Active Traders
- Near-term upside to $13.62 (+1.4%) if momentum holds
- Stop-loss prudent below $12.75 (recent consolidation low)
- Watch for volume confirmation on breakout attempts
Longer-Term Investors
- High debt load raises sustainability questions
- Negative growth contrasts with strong ROE - warrants deeper due diligence
- Sector outlook for health analytics remains favorable despite company-specific risks
Recommended Action Plan
- Day Traders: Scalp $13.15-13.45 range with tight stops
- Swing Traders: Consider long positions above $13.30 targeting $13.62 exit
- Risk-Averse Investors: Monitor debt management progress before entry
Data reflects market conditions as of November 3, 2025 closing. Past performance ≠ future results. Consult a financial advisor before trading. Volatility risk elevated with 52-week range of $9.76-$21.64.
Prédiction IABeta
Recommandation IA
Mis à jour le: 10 nov. 2025, 13:54
65.2% Confiance
Risque et Trading
Point d'Entrée
$14.43
Prise de Bénéfices
$15.02
Stop Loss
$13.26
Facteurs Clés
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.